Xiang Zhou to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Xiang Zhou has written about Carcinoma, Hepatocellular.
Connection Strength
0.809
-
Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. Hepatol Commun. 2026 Jul 01; 10(7).
Score: 0.176
-
Serum Proteomic Profile Based on the TGF-ß Pathway Stratifies Risk of Hepatocellular Carcinoma. Liver Int. 2025 10; 45(10):e70325.
Score: 0.168
-
Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients. J Exp Clin Cancer Res. 2025 May 01; 44(1):136.
Score: 0.163
-
Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation. PLoS One. 2025; 20(4):e0321736.
Score: 0.163
-
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma. Hepatology. 2023 03 01; 77(3):774-788.
Score: 0.140